Since tumor mutational burden (TMB) and microsatellite instability (MSI) are key factors in predicting the efficacy of immunotherapy, we assessed the correlation between LIPT2 expression and pan-cancer TMB and MSI. This evidence concerns the gene LIPT2 and neoplasm.